BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji Y, Chen S, Xiang B, Xu Z, Jiang X, Liu X, Wang Q, Lu G, Yang L. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Sci Rep 2016;6:31744. [PMID: 27530723 DOI: 10.1038/srep31744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Grzesik P, Wu JK. Current perspectives on the optimal management of infantile hemangioma. Pediatric Health Med Ther 2017;8:107-16. [PMID: 29388636 DOI: 10.2147/PHMT.S115528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yang K, Feng L, Chen S, Ji Y. Progressive infantile hepatic hemangioma not responding to propranolol. J Dermatol 2019;46:e275-6. [PMID: 30821839 DOI: 10.1111/1346-8138.14833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ji Y, Chen S, Yang K, Xiang B, Jiang X, Xu X, Li L, Qiu T, Zhou J, Dai S, Zhang X, Lu G, Kong F, Yang G, Qiu Q. Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study. J Am Acad Dermatol 2021;84:1378-84. [PMID: 33285272 DOI: 10.1016/j.jaad.2020.11.062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ji Y, Chen S, Xiang B, Yang Y, Qiu L. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study. Sci Rep 2017;7:1503. [PMID: 28473717 DOI: 10.1038/s41598-017-01321-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
5 Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, Chen S, Ji Y. Quality of life in children with infantile hemangioma: a case control study. Health Qual Life Outcomes 2017;15:221. [PMID: 29145889 DOI: 10.1186/s12955-017-0772-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G. Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 2020;179:1-8. [DOI: 10.1007/s00431-019-03504-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Wessman LL, Mori WS, Totoraitis K, Murati M, Maguiness S. Multifocal infantile hemangiomas associated with concomitant giant hepatic rapidly involuting congenital hemangioma. Pediatr Dermatol 2020;37:972-3. [PMID: 32648264 DOI: 10.1111/pde.14278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 López-gutiérrez J. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. Eur J Pediatr 2019;178:1-6. [DOI: 10.1007/s00431-018-3290-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Valdebran M, Wine Lee L. Hemangioma-related syndromes. Current Opinion in Pediatrics 2020;32:498-505. [DOI: 10.1097/mop.0000000000000925] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang C, Wang Q, Xiang B, Chen S, Xiong F, Ji Y. Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study. Biomed Res Int 2018;2018:5821369. [PMID: 29682550 DOI: 10.1155/2018/5821369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Yang K, Peng S, Chen L, Chen S, Ji Y. Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 2019;55:1194-200. [DOI: 10.1111/jpc.14375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ji Y, Chen S, Wang Q, Xiang B, Xu Z, Zhong L, Yang K, Lu G, Qiu L. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Sci Rep 2018;8:4264. [PMID: 29523832 DOI: 10.1038/s41598-018-22787-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
13 Lucas B, Ravishankar S, Pateva I. Pediatric Primary Hepatic Tumors: Diagnostic Considerations. Diagnostics (Basel) 2021;11:333. [PMID: 33670452 DOI: 10.3390/diagnostics11020333] [Reference Citation Analysis]